REPLY
- PMID: 33959991
- DOI: 10.1002/hep.31887
REPLY
Comment on
-
Responsible Inclusion of Pregnant Individuals in Eradicating HCV.Hepatology. 2021 Sep;74(3):1645-1651. doi: 10.1002/hep.31825. Epub 2021 Jun 4. Hepatology. 2021. PMID: 33743550
-
Letter to the Editor: Pregnant Women and their Providers Want Direct-Acting Antivirals, and We Are Missing the Mark.Hepatology. 2021 Oct;74(4):2311-2312. doi: 10.1002/hep.31885. Epub 2021 Jul 27. Hepatology. 2021. PMID: 33959998 No abstract available.
References
Reference
-
- Yee LM, Shah SK, Grobman WA, Labellarte PZ, Barerra L, Jhaveri R. Identifying barriers to the inclusion of pregnant patients in hepatitis C research and treatment programs. Am J Obstet Gynecol 2021;2021:S358-S359.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
